Impact of COVID-19 in solid organ transplant recipients |
| |
| Authors: | Lara Danziger-Isakov Emily A. Blumberg Oriol Manuel Martina Sester |
| |
| Affiliation: | 1. Department of Pediatrics, Cincinnati Children’s Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA;2. Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA;3. Infectious Diseases Service and Transplantation Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland;4. Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany |
| |
| Abstract: | ![]()
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early 2020. The impact on solid organ transplantation (SOT) has been profound affecting potential donors, candidates, and recipients. Importantly, decreased donations and the pressure of limited resources placed on health care by the pandemic also disrupted transplant systems. We address the impact of COVID-19 on organ transplantation globally and review current understanding of the epidemiology, outcomes, diagnosis, and treatment of COVID-19 in SOT recipients. |
| |
| Keywords: | antibiotic: antiviral COVID-19 health services and outcomes research viewpoint infectious disease United infection and infectious agents - viral immunosuppression / immune modulation organ procurement organ transplantation in general |
|
|
